Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice
Abstract Glucocorticoids (GCs), such as prednisolone, are widely used to treat inflammatory diseases. Continuously long-term or high dose treatment with GCs is one of the most common causes of secondary osteoporosis and is associated with sarcopenia and increased risk of debilitating osteoporotic fr...
Guardado en:
Autores principales: | Mikkel Bo Brent, Jesper Skovhus Thomsen, Annemarie Brüel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fe83de89c45641bd870184408434e0c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sparse dose-dependent difference in skeletal effects of short-term glucocorticoid excess in outbred Swiss mice
por: Mikkel Bo Brent, et al.
Publicado: (2021) -
Abaloparatide and the Spine: A Narrative Review
por: Thompson JC, et al.
Publicado: (2020) -
Glucocorticoids induce osteonecrosis of the femoral head through the Hippo signaling pathway
por: Li Yugang, et al.
Publicado: (2021) -
Excessive salt consumption causes systemic calcium mishandling and worsens microarchitecture and strength of long bones in rats
por: Wacharaporn Tiyasatkulkovit, et al.
Publicado: (2021) -
The use of abaloparatide to treat nonunion following dorsal closing wedge osteotomy for Freiberg's disease: A case report
por: Jessica A. Nelson, et al.
Publicado: (2021)